News
TK1 in cats
A recently published scientific paper by researchers associated with Alertix displays TK1 in cat serum to be significantly higher compared to healthy cats and compared to cats with inflammatory diseases. These results suggest that serum TK1 may be a promising biomarker for the diagnosis and monitoring of malignant diseases and for the differential diagnosis of certain inflammatory diseases.
Read moreNew Board Member
Press releaseM.Sc. Göran Beijer was elected as a new board member of Alertix at an extraordinary general meeting on the 17th of December 2019.
Read moreSupport from Vinnova
Press releaseMore support for Alertix’ acclaimed research. This time from Sweden’s Innovation Agency Vinnova.
Read moreAlertix – Winner of the Innovation Award in Kalmar County
Press releaseToday, Alertix received the innovation award SKAPA at a ceremony at the governor’s residence by the Governor Thomas Carlzon. Besides of the money-based award, Alertix will also be a participant in the national innovation award in November at Älvsjö, Sweden, when the Swedish master of innovation will be announced.
Read moreAlertix® registered as trademark
Alertix® is now registered as trademark both in Europe and internationally
Read moreBiomarkers to improve cancer care
At an international conference in Uppsala Sweden, Uppsala Health Summit 14-15 June 2018, professor Henrik Rönnberg, SLU Uppsala, co-organized a workshop named Towards Useful Cancer Biomarkers to Improve Cancer Care.
Read moreTechnical advances offer new potential to TK1 as a tumor biomarker
A recently published review paper highlights TK1 as a tumor biomarker
Read moreBiomarkers to improve care for cancer
Today, at an international conference in Uppsala Sweden, Uppsala Health Summit 14-15 June 2018, professor Henrik Rönnberg, SLU Uppsala, co-organized a workshop named Towards Useful Cancer Biomarkers to Improve Cancer Care.
Read moreHenrik Rönnberg will lecture at the Nordic Small Animal Veterinary Conference
Oncology is the main theme of the BSA Congress of 2018, which will be arranged in Gothenburg at the end of January.
Alertix’ Henrik Rönnberg will be one of the lecturers. Henrik will, among other things, talk about new methods to treat cancer in animals.
Alertix homepage – now in English
Welcome to Alertix Veterinary Diagnostic’s international website .
Read moreSwedish research behind unique cancer test for pets
Press releaseCancer is just as common in companion animals as in humans. Cancer therapy is improving and in many cases the disease can be treated with success. However early diagnosis is crucial for successful treatment. Therefore, a new, unique cancer test can come to be of great significance.
Read moreAnimal owners in favor of cancer test
One out of four responding animal owners are in favor of using a test for early detection of cancer in their pets. More than 40 percent are willing to pay equivalent to 70 USD or more of their own money for the test, and 50 percent might consider asking their veterinarian for a test.
Read more